Beta Bionics, Inc. Increase Decrease In Operating Lease Liability
Beta Bionics, Inc. (BBNX) reported Increase Decrease In Operating Lease Liability of -$791.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-29
- Beta Bionics, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$400.00K.
- Beta Bionics, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$391.00K.
- Beta Bionics, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$384.00K.
- Beta Bionics, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$285.00K.
- Beta Bionics, Inc. increase decrease in operating lease liability for fiscal 2025 was -$1.24M.
- Beta Bionics, Inc. increase decrease in operating lease liability for fiscal 2024 was -$1.02M.
- Beta Bionics, Inc. increase decrease in operating lease liability for fiscal 2023 was -$948.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$791.00K 10-Q · filed 2026-07-29 | -$1.18M derived: sum of 3 quarters · filed 2026-07-29 | -$1.46M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$391.00K 10-Q · filed 2026-04-21 | -$775.00K derived: sum of 2 quarters · filed 2026-04-21 | -$1.06M derived: sum of 3 quarters · filed 2026-04-21 | -$1.35M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$669.00K derived: sum of 2 quarters · filed 2026-02-24 | -$955.00K derived: sum of 3 quarters · filed 2026-07-29 | -$1.24M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$285.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$571.00K derived: sum of 2 quarters · filed 2026-07-29 | -$852.00K 10-Q · filed 2025-10-28 | -$1.13M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$286.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$567.00K 10-Q · filed 2026-07-29 | -$840.00K derived: sum of 3 quarters · filed 2026-07-29 | -$1.14M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$281.00K 10-Q · filed 2026-04-21 | -$554.00K derived: sum of 2 quarters · filed 2026-04-21 | -$850.00K derived: sum of 3 quarters · filed 2026-04-21 | -$1.08M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | -$273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$569.00K derived: sum of 2 quarters · filed 2026-02-24 | -$799.00K derived: sum of 3 quarters · filed 2026-02-24 | -$1.02M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$296.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$526.00K derived: sum of 2 quarters · filed 2025-10-28 | -$750.00K 10-Q · filed 2025-10-28 | |
| 2024-06-30 | -$230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$454.00K 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | -$224.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | -$948.00K 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |